Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study

Keyphrases

• Placebo-controlled 100%
• Obsessive-compulsive Disorder 100%
• Controlled Crosses 100%
• Naltrexone 100%
• Placebo 60%
• MADRS 40%
• Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) 40%
• OC Symptoms 40%
• Hamas 40%
• Randomized Double-blind 20%
• High-score 20%
• Compulsion 20%
• Addiction 20%
• Current Treatment 20%
• Behavioral Similarity 20%
• Adequate Dose 20%
• Clomipramine 20%
• Chronically Ill 20%
• Selective Serotonin Reuptake Inhibitors 20%
• Compulsive Behavior 20%
• Multivariate Analysis of Variance 20%
• Opioid Antagonist 20%
• Crossover Design 20%
• Ceiling Effect 20%
• Serotonergic System 20%

Medicine and Dentistry

• Placebo 100%
• Obsessive Compulsive Disorder 100%
• Naltrexone 100%
• Montgomery-Åsberg Depression Rating Scale 40%
• Yale-Brown Obsessive Compulsive Scale 40%
• Compulsive Behavior 40%
• Addictive Behavior 20%
• Serotonin 20%
• Selective Serotonin Reuptake Inhibitor 20%
• Outpatient 20%
• Reuptake Inhibitor 20%
• Clomipramine 20%
• Opiate Antagonist 20%
• Multivariate Analysis of Variance 20%

Neuroscience

• Placebo 100%
• Crossover Study 100%
• Obsessive-Compulsive Disorder 100%
• Naltrexone 100%
• Compulsive Behavior 40%
• Clomipramine 20%
• Selective Serotonin Reuptake Inhibitor 20%
• Serotonergic 20%
• Narcotic Antagonist 20%
• Serotonin Reuptake Inhibitor 20%